Estrella Immunopharma annual total assets
2021
2022
2022
2023
2024
2024
2025
Estrella Immunopharma Total Assets Growth & History (ESLA)
Estrella Immunopharma's total assets was $3.2M for fiscal 2025.
View full Estrella Immunopharma company overviewEstrella Immunopharma annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.2M | $36,198 | +1.15% |
| 2024 · Dec 31 | 2024-12-31 | $3.1M | — | — |
| 2024 · Jun 30 | 2024-06-30 | $4.5M | $1.4M | +47.08% |
| 2023 | 2023-06-30 | $3.0M | −$1.9M | −38.47% |
| 2022 | 2022-12-31 | $9.7M | −$36.1M | −78.77% |
| 2022 | 2022-06-30 | $4.9M | — | — |
| 2021 | 2021-12-31 | $45.8M | — | — |
Estrella Immunopharma quarterly total assets
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.8M | −$1.2M | −38.78% |
| Q1 2026 | 2026-03-31 | $3.7M | $1.2M | +49.62% |
| Q4 2025 | 2025-12-31 | $3.2M | $36,198 | +1.15% |
| Q3 2025 | 2025-09-30 | $3.5M | −$211,634 | −5.67% |
| Q2 2025 | 2025-06-30 | $3.0M | −$1.5M | −33.08% |
| Q1 2025 · Mar 31 | 2025-03-31 | $2.4M | −$6.2M | −71.69% |
| Q4 2024 · Dec 31 | 2024-12-31 | $3.1M | −$6.3M | −66.75% |
| Q1 2025 · Sep 30 | 2024-09-30 | $3.7M | −$23.6M | −86.34% |
| Q4 2024 · Jun 30 | 2024-06-30 | $4.5M | $1.4M | +47.08% |
| Q3 2024 | 2024-03-31 | $8.6M | — | — |
| Q2 2024 | 2023-12-31 | $9.4M | −$276,539 | −2.84% |
| Q1 2024 | 2023-09-30 | $27.3M | −$18.3M | −40.05% |
| Q4 2023 | 2023-06-30 | $3.0M | −$42.4M | −93.33% |
| Q4 2022 | 2022-12-31 | $9.7M | −$36.1M | −78.77% |
| Q3 2022 | 2022-09-30 | $45.6M | −$346,344 | −0.75% |
| Q2 2022 | 2022-06-30 | $45.4M | — | — |
| Q1 2022 | 2022-03-31 | $45.6M | — | — |
| Q4 2021 | 2021-12-31 | $45.8M | — | — |
| Q3 2021 | 2021-09-30 | $46.0M | — | — |
Estrella Immunopharma total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, Estrella Immunopharma's total assets decreased from $45.8M to $3.2M, a change of −$42.6M. The latest reported quarter, Q2 2026, shows $1.8M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Estrella Immunopharma source filings ↗